Stocks · Health care · Pharmaceutical Preparations

Travere Therapeutics, Inc.

TVTX Clue Score50
United States Fiscal year ends December CIK 0001438533
52.13
+0.16%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
52.13 on 9 Oct 2026
68 47 26 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $26.20 14 Oct 2025 $26.14 15 Oct 2025 $26.85 16 Oct 2025 $27.51 17 Oct 2025 $27.32 20 Oct 2025 $27.89 21 Oct 2025 $27.80 22 Oct 2025 $27.48 23 Oct 2025 $28.15 24 Oct 2025 $28.06 27 Oct 2025 $29.77 28 Oct 2025 $29.81 29 Oct 2025 $29.98 30 Oct 2025 $29.65 31 Oct 2025 $35.16 3 Nov 2025 $34.53 4 Nov 2025 $34.13 5 Nov 2025 $33.72 6 Nov 2025 $33.30 7 Nov 2025 $32.34 10 Nov 2025 $34.38 11 Nov 2025 $36.11 12 Nov 2025 $36.47 13 Nov 2025 $33.89 14 Nov 2025 $34.50 17 Nov 2025 $35.44 18 Nov 2025 $36.00 19 Nov 2025 $35.43 20 Nov 2025 $34.73 21 Nov 2025 $34.69 24 Nov 2025 $35.79 25 Nov 2025 $36.01 26 Nov 2025 $36.26 28 Nov 2025 $35.41 1 Dec 2025 $35.19 2 Dec 2025 $33.99 3 Dec 2025 $34.85 4 Dec 2025 $35.33 5 Dec 2025 $35.00 8 Dec 2025 $34.29 9 Dec 2025 $34.51 10 Dec 2025 $34.38 11 Dec 2025 $35.01 12 Dec 2025 $34.83 15 Dec 2025 $34.76 16 Dec 2025 $35.85 17 Dec 2025 $33.89 18 Dec 2025 $34.49 19 Dec 2025 $34.51 22 Dec 2025 $36.50 23 Dec 2025 $35.36 24 Dec 2025 $40.28 26 Dec 2025 $39.64 29 Dec 2025 $38.88 30 Dec 2025 $37.68 31 Dec 2025 $38.21 2 Jan 2026 $39.52 5 Jan 2026 $38.11 6 Jan 2026 $35.80 7 Jan 2026 $36.28 8 Jan 2026 $35.60 9 Jan 2026 $34.58 12 Jan 2026 $34.10 13 Jan 2026 $29.11 14 Jan 2026 $28.93 15 Jan 2026 $28.40 16 Jan 2026 $27.87 20 Jan 2026 $27.94 21 Jan 2026 $28.25 22 Jan 2026 $29.73 23 Jan 2026 $29.44 26 Jan 2026 $29.94 27 Jan 2026 $30.03 28 Jan 2026 $30.28 29 Jan 2026 $31.99 30 Jan 2026 $31.09 2 Feb 2026 $33.10 3 Feb 2026 $32.84 4 Feb 2026 $31.68 5 Feb 2026 $29.47 6 Feb 2026 $29.71 9 Feb 2026 $30.07 10 Feb 2026 $30.32 11 Feb 2026 $30.22 12 Feb 2026 $30.60 13 Feb 2026 $27.82 17 Feb 2026 $28.75 18 Feb 2026 $27.87 19 Feb 2026 $29.30 20 Feb 2026 $30.39 23 Feb 2026 $30.73 24 Feb 2026 $30.88 25 Feb 2026 $29.34 26 Feb 2026 $29.72 27 Feb 2026 $29.79 2 Mar 2026 $29.53 3 Mar 2026 $28.27 4 Mar 2026 $28.18 5 Mar 2026 $27.31 6 Mar 2026 $27.24 9 Mar 2026 $28.98 10 Mar 2026 $28.63 11 Mar 2026 $28.47 12 Mar 2026 $27.55 13 Mar 2026 $27.80 16 Mar 2026 $28.03 17 Mar 2026 $27.76 18 Mar 2026 $26.96 19 Mar 2026 $27.72 20 Mar 2026 $26.84 23 Mar 2026 $27.75 24 Mar 2026 $26.79 25 Mar 2026 $27.56 26 Mar 2026 $27.92 27 Mar 2026 $27.25 30 Mar 2026 $27.66 31 Mar 2026 $29.71 1 Apr 2026 $31.42 2 Apr 2026 $30.44 6 Apr 2026 $31.83 7 Apr 2026 $31.67 8 Apr 2026 $31.68 9 Apr 2026 $31.44 10 Apr 2026 $28.96 13 Apr 2026 $30.70 14 Apr 2026 $42.13 15 Apr 2026 $40.95 16 Apr 2026 $39.54 17 Apr 2026 $40.77 20 Apr 2026 $40.29 21 Apr 2026 $38.78 22 Apr 2026 $40.09 23 Apr 2026 $40.82 24 Apr 2026 $40.50 27 Apr 2026 $40.81 28 Apr 2026 $40.89 29 Apr 2026 $40.10 30 Apr 2026 $42.12 1 May 2026 $44.12 4 May 2026 $44.91 5 May 2026 $44.80 6 May 2026 $44.76 7 May 2026 $42.66 8 May 2026 $42.60 11 May 2026 $43.51 12 May 2026 $42.84 13 May 2026 $44.55 14 May 2026 $44.10 15 May 2026 $42.59 18 May 2026 $42.89 19 May 2026 $42.26 20 May 2026 $43.49 21 May 2026 $44.74 22 May 2026 $44.43 26 May 2026 $44.29 27 May 2026 $47.76 28 May 2026 $47.76 29 May 2026 $47.18 1 Jun 2026 $45.04 2 Jun 2026 $42.96 3 Jun 2026 $45.20 4 Jun 2026 $46.18 5 Jun 2026 $45.81 8 Jun 2026 $47.08 9 Jun 2026 $48.57 10 Jun 2026 $46.74 11 Jun 2026 $48.91 12 Jun 2026 $52.04 15 Jun 2026 $53.80 16 Jun 2026 $53.38 17 Jun 2026 $54.14 18 Jun 2026 $55.15 22 Jun 2026 $55.11 23 Jun 2026 $55.95 24 Jun 2026 $57.69 25 Jun 2026 $59.03 26 Jun 2026 $58.85 29 Jun 2026 $58.30 30 Jun 2026 $56.81 1 Jul 2026 $56.34 2 Jul 2026 $56.92 6 Jul 2026 $57.48 7 Jul 2026 $57.85 8 Jul 2026 $58.36 9 Jul 2026 $58.47 10 Jul 2026 $56.59 13 Jul 2026 $56.29 14 Jul 2026 $57.06 15 Jul 2026 $56.74 16 Jul 2026 $55.28 17 Jul 2026 $56.71 20 Jul 2026 $55.47 21 Jul 2026 $56.58 22 Jul 2026 $56.26 23 Jul 2026 $56.68 24 Jul 2026 $57.36 27 Jul 2026 $56.68 28 Jul 2026 $55.91 29 Jul 2026 $55.56 30 Jul 2026 $57.28 31 Jul 2026 $55.89 3 Aug 2026 $54.98 4 Aug 2026 $56.02 5 Aug 2026 $62.76 6 Aug 2026 $62.45 7 Aug 2026 $61.32 10 Aug 2026 $60.89 11 Aug 2026 $60.21 12 Aug 2026 $62.16 13 Aug 2026 $61.43 14 Aug 2026 $62.14 17 Aug 2026 $63.53 18 Aug 2026 $63.90 19 Aug 2026 $65.96 20 Aug 2026 $64.46 21 Aug 2026 $65.71 24 Aug 2026 $65.22 25 Aug 2026 $67.01 26 Aug 2026 $67.12 27 Aug 2026 $67.52 28 Aug 2026 $65.67 31 Aug 2026 $66.28 1 Sep 2026 $65.71 2 Sep 2026 $67.23 3 Sep 2026 $66.54 4 Sep 2026 $65.28 8 Sep 2026 $66.07 9 Sep 2026 $66.22 10 Sep 2026 $67.51 11 Sep 2026 $66.17 14 Sep 2026 $65.79 15 Sep 2026 $62.51 16 Sep 2026 $63.48 17 Sep 2026 $64.74 18 Sep 2026 $62.76 21 Sep 2026 $62.86 22 Sep 2026 $60.28 23 Sep 2026 $59.83 24 Sep 2026 $60.62 25 Sep 2026 $59.44 28 Sep 2026 $61.57 29 Sep 2026 $59.99 30 Sep 2026 $58.88 1 Oct 2026 $56.85 2 Oct 2026 $56.93 5 Oct 2026 $57.67 6 Oct 2026 $55.98 7 Oct 2026 $53.44 8 Oct 2026 $52.04 9 Oct 2026 $52.13 Heerma Peter CHIEF COMMERCIAL OFFICER Sold on a plan $79.86K 28 Oct 2025 · at $30.00 · 2.1% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $2.82M 28 Oct 2025 · at $30.38 · 18.1% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $817.07K 29 Oct 2025 · at $30.12 · 6.1% of stake Heerma Peter CHIEF COMMERCIAL OFFICER Sold on a plan $195.69K 31 Oct 2025 · at $35.00 · 4.5% of stake Coughlin Timothy Director Sold on a plan $630.60K 31 Oct 2025 · at $35.03 · 24.5% of stake Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sold on a plan $2.42M 4 Nov 2025 · at $36.00 · 58.0% of stake Cline Christopher R. CHIEF FINANCIAL OFFICER Sold on a plan $700.20K 1 Dec 2025 · at $35.01 · 17.8% of stake Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sold on a plan $104.76K 15 Dec 2025 · at $36.00 · 6.0% of stake Heerma Peter CHIEF COMMERCIAL OFFICER Sold on a plan $199.20K 24 Dec 2025 · at $40.00 · 4.2% of stake Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sold on a plan $296.08K 24 Dec 2025 · at $40.00 · 16.2% of stake Inrig Jula CHIEF MEDICAL OFFICER Sold on a plan $630.00K 24 Dec 2025 · at $42.00 · 14.5% of stake ROTE WILLIAM E. Chief Research Officer Sold on a plan $2.41M 24 Dec 2025 · at $40.10 · 37.2% of stake Inrig Jula CHIEF MEDICAL OFFICER Sold on a plan $81.61K 5 Jan 2026 · at $40.18 · 2.3% of stake Inrig Jula CHIEF MEDICAL OFFICER Sold on a plan $16.80K 6 Jan 2026 · at $37.75 · 0.5% of stake REED ELIZABETH E Chief Legal Officer and GC Sold on a plan $273.42K 20 Jan 2026 · at $27.34 · 10.0% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $244.15K 23 Jan 2026 · at $30.01 · 1.9% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $1.56M 27 Jan 2026 · at $30.10 · 11.0% of stake Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sold at will $139.18K 3 Feb 2026 · at $32.12 · 8.1% of stake Inrig Jula CHIEF MEDICAL OFFICER Sold at will $223.43K 3 Feb 2026 · at $32.12 · 6.1% of stake REED ELIZABETH E Chief Legal Officer and GC Sold at will $230.46K 3 Feb 2026 · at $32.12 · 6.2% of stake Cline Christopher R. CHIEF FINANCIAL OFFICER Sold at will $232.61K 3 Feb 2026 · at $32.12 · 6.0% of stake Heerma Peter CHIEF COMMERCIAL OFFICER Sold at will $234.80K 3 Feb 2026 · at $32.12 · 5.3% of stake ROTE WILLIAM E. Chief Research Officer Sold on a plan $409.10K 3 Feb 2026 · at $32.87 · 10.2% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $3.23M 3 Feb 2026 · at $32.28 · 18.8% of stake Cline Christopher R. CHIEF FINANCIAL OFFICER Sold on a plan $56.17K 4 Feb 2026 · at $32.19 · 1.5% of stake Inrig Jula CHIEF MEDICAL OFFICER Sold on a plan $57.30K 4 Feb 2026 · at $32.21 · 1.7% of stake REED ELIZABETH E Chief Legal Officer and GC Sold on a plan $96.36K 4 Feb 2026 · at $32.18 · 2.8% of stake REED ELIZABETH E Chief Legal Officer and GC Sold on a plan $278.32K 17 Feb 2026 · at $27.83 · 8.7% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $1.81M 20 Feb 2026 · at $30.10 · 12.2% of stake REED ELIZABETH E Chief Legal Officer and GC Sold on a plan $280.86K 16 Mar 2026 · at $28.09 · 8.7% of stake REED ELIZABETH E Chief Legal Officer and GC Sold on a plan $300.00K 1 Apr 2026 · at $30.00 · 8.7% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $1.86M 1 Apr 2026 · at $30.93 · 12.2% of stake Baynes Roy D. Director Sold on a plan $330.00K 6 Apr 2026 · at $33.00 · 21.1% of stake Cline Christopher R. CHIEF FINANCIAL OFFICER Sold on a plan $1.88K 13 Apr 2026 · at $28.85 · 0.1% of stake Heerma Peter CHIEF COMMERCIAL OFFICER Sold at will $302.52K 14 Apr 2026 · at $41.93 · 4.9% of stake Inrig Jula CHIEF MEDICAL OFFICER Sold on a plan $302.52K 14 Apr 2026 · at $41.93 · 6.0% of stake Cline Christopher R. CHIEF FINANCIAL OFFICER Sold on a plan $303.89K 14 Apr 2026 · at $41.93 · 5.8% of stake LYONS GARY A Director Sold on a plan $328.56K 14 Apr 2026 · at $41.07 · 12.2% of stake Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sold on a plan $902.60K 14 Apr 2026 · at $41.07 · 34.2% of stake Baynes Roy D. Director Sold on a plan $1.35M 14 Apr 2026 · at $41.29 · 46.6% of stake REED ELIZABETH E Chief Legal Officer and GC Sold on a plan $1.84M 14 Apr 2026 · at $41.21 · 28.5% of stake Cline Christopher R. CHIEF FINANCIAL OFFICER Sold on a plan $43.21K 15 Apr 2026 · at $42.61 · 0.9% of stake Inrig Jula CHIEF MEDICAL OFFICER Sold on a plan $43.38K 15 Apr 2026 · at $42.61 · 0.9% of stake REED ELIZABETH E Chief Legal Officer and GC Sold on a plan $283.81K 15 Apr 2026 · at $41.83 · 6.1% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $2.63M 15 Apr 2026 · at $41.09 · 12.9% of stake ROTE WILLIAM E. Chief Research Officer Sold on a plan $355.72K 22 Apr 2026 · at $39.09 · 7.4% of stake Baynes Roy D. Director Sold on a plan $431.15K 1 May 2026 · at $44.22 · 20.6% of stake Meckler Jeffrey A Director Sold on a plan $360.00K 4 May 2026 · at $45.00 · 8.4% of stake REED ELIZABETH E Chief Legal Officer and GC Sold on a plan $900.00K 4 May 2026 · at $45.00 · 16.0% of stake Inrig Jula CHIEF MEDICAL OFFICER Sold on a plan $900.00K 4 May 2026 · at $45.00 · 15.2% of stake REED ELIZABETH E Chief Legal Officer and GC Sold on a plan $101.42K 5 May 2026 · at $46.65 · 2.0% of stake Inrig Jula CHIEF MEDICAL OFFICER Sold on a plan $101.42K 5 May 2026 · at $46.65 · 1.9% of stake Heerma Peter CHIEF COMMERCIAL OFFICER Sold at will $101.42K 5 May 2026 · at $46.65 · 1.5% of stake Cline Christopher R. CHIEF FINANCIAL OFFICER Sold on a plan $101.74K 5 May 2026 · at $46.65 · 1.8% of stake Baynes Roy D. Director Sold on a plan $209.93K 5 May 2026 · at $46.65 · 10.7% of stake Cline Christopher R. CHIEF FINANCIAL OFFICER Sold on a plan $13.62K 6 May 2026 · at $43.95 · 0.3% of stake Inrig Jula CHIEF MEDICAL OFFICER Sold on a plan $13.67K 6 May 2026 · at $43.95 · 0.3% of stake REED ELIZABETH E Chief Legal Officer and GC Sold on a plan $91.24K 6 May 2026 · at $43.95 · 1.9% of stake ROTE WILLIAM E. Chief Research Officer Sold on a plan $121.43K 6 May 2026 · at $43.95 · 2.3% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $988.88K 6 May 2026 · at $43.95 · 4.9% of stake Coughlin Timothy Director Sold on a plan $141.34K 15 May 2026 · at $43.49 · 5.9% of stake Baynes Roy D. Director Sold on a plan $225.00K 12 Jun 2026 · at $50.00 · 9.8% of stake Coughlin Timothy Director Sold on a plan $500.75K 12 Jun 2026 · at $50.07 · 15.1% of stake LYONS GARY A Director Sold on a plan $315.99K 17 Aug 2026 · at $63.20 · 7.5% of stake LYONS GARY A Director Sold on a plan $316.86K 18 Aug 2026 · at $63.37 · 7.5% of stake Cline Christopher R. CHIEF FINANCIAL OFFICER Sold at will $42.61K 2 Sep 2026 · at $66.37 · 0.5% of stake Meckler Jeffrey A Director Sold on a plan $1.35M 10 Sep 2026 · at $67.31 · 17.9% of stake Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sold on a plan $335.00K 15 Sep 2026 · at $62.33 · 11.3% of stake REED ELIZABETH E Chief Legal Officer and GC Sold on a plan $2.34M 15 Sep 2026 · at $62.34 · 26.2% of stake Inrig Jula EVP, Head of R&D & CMO Sold on a plan $2.79M 15 Sep 2026 · at $62.34 · 30.8% of stake Cline Christopher R. CHIEF FINANCIAL OFFICER Sold on a plan $3.15M 15 Sep 2026 · at $62.34 · 36.6% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $5.96M 15 Sep 2026 · at $62.26 · 18.1% of stake ROTE WILLIAM E. Chief Research Officer Sold on a plan $5.99M 15 Sep 2026 · at $62.25 · 49.5% of stake Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Sold on a plan $6.36M 15 Sep 2026 · at $62.26 · 46.6% of stake ROTE WILLIAM E. Chief Research Officer Sold on a plan $7.15M 16 Sep 2026 · at $63.33 · 53.5% of stake Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Sold on a plan $10.96M 16 Sep 2026 · at $63.43 · 59.6% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $12.43M 16 Sep 2026 · at $63.45 · 31.1% of stake Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Sold on a plan $538.92K 17 Sep 2026 · at $65.07 · 6.6% of stake Dube Eric M CHIEF EXECUTIVE OFFICER Sold on a plan $7.01M 17 Sep 2026 · at $64.61 · 20.0% of stake
0 buys8 sales at will71 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$490.73M
Net income
$25.55M
Free cash flow
$37.78M
Operating margin
-12.8%
Net margin
-5.2%
Return on equity
-22.3%
Return on capital
-43.2%
Revenue growth, 1 yr
110.5%
Revenue growth, 5 yr
19.9% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
198M -169M FY20 Fiscal year 2020 Revenue $198.32M Net income $169.43M Margin -85.4% 132M -180M FY21 Fiscal year 2021 Revenue $131.84M Net income $180.09M Margin -136.6% · growth -33.5% 109M -278M FY22 Fiscal year 2022 Revenue $109.46M Net income $278.48M Margin -254.4% · growth -17.0% 145M -111M FY23 Fiscal year 2023 Revenue $145.24M Net income $111.40M Margin -76.7% · growth +32.7% 233M -322M FY24 Fiscal year 2024 Revenue $233.18M Net income $321.55M Margin -137.9% · growth +60.5% 491M -26M FY25 Fiscal year 2025 Revenue $490.73M Net income $25.55M Margin -5.2% · growth +110.5%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
17 Sep 2026 Dube Eric M
CHIEF EXECUTIVE OFFICER
Sold on a plan $7.01M 20.0%
17 Sep 2026 Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Sold on a plan $538.92K 6.6%
16 Sep 2026 Dube Eric M
CHIEF EXECUTIVE OFFICER
Sold on a plan $12.43M 31.1%
16 Sep 2026 Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Sold on a plan $10.96M 59.6%
16 Sep 2026 ROTE WILLIAM E.
Chief Research Officer
Sold on a plan $7.15M 53.5%
15 Sep 2026 Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Sold on a plan $6.36M 46.6%